title: Procathepsin D and cancer: From molecular biology to clinical applications.
abstract: Procathepsin D (pCD) is overexpressed and secreted by cells of various tumor types including breast and lung carcinomas. pCD affects multiple features of tumor cells including proliferation, invasion, metastases and apoptosis. Several laboratories have previously shown that the mitogenic effect of pCD on cancer cells is mediated via its propeptide part (APpCD). However, the exact mechanism of how pCD affects cancer cells has not been identified. Recent observations have also revealed the possible use of pCD/APpcD as a marker of cancer progression. The purpose of this review is to summarize the three major potentials of pCD-tumor marker, potential drug, and screening agent.
authors: Vaclav Vetvicka, Jana Vetvickova, Department of Pathology, University of Louisville, Louisville, KY 40202, United States.
authors: Vaclav
authors: V
authors: Vetvicka
authors: Aruna
authors: A
authors: Vashishta
authors: Sujata
authors: S
authors: Saraswat-Ohri
authors: Jana
authors: J
authors: Vetvickova
references: Am J Physiol. 1989 Dec;257(6 Pt 1):C1069-79
references: 2610247
references: Biochemistry. 1992 Feb 4;31(4):1142-7
references: 1734961
references: Adv Exp Med Biol. 1995;362:273-8
references: 8540327
references: Br J Cancer. 1997;76(5):661-6
references: 9303368
references: J Cell Sci. 1999 May;112 ( Pt 10):1591-7
references: 10212152
references: J Cell Sci. 1974 Jan;14(1):139-61
references: 4131578
references: EMBO J. 1993 Apr;12(4):1293-302
references: 8467789
references: Eur J Cancer. 2000 Jul;36(11):1374-80
references: 10899650
references: Cancer Lett. 1998 Jul 3;129(1):55-9
references: 9714335
references: Cancer Res. 1988 Jan 15;48(2):362-7
references: 2825973
references: Endocr Metab Immune Disord Drug Targets. 2009 Dec;9(4):385-91
references: 19807669
references: Adv Exp Med Biol. 1991;306:289-96
references: 1812719
references: J Biol Chem. 1991 Dec 15;266(35):23586-92
references: 1660878
references: J Biol Chem. 1980 May 25;255(10):4946-50
references: 6989822
references: Clin Exp Metastasis. 2004;21(2):91-106
references: 15168727
references: EMBO J. 1995 Aug 1;14(15):3599-608
references: 7641679
references: J Biol Chem. 1981 Nov 10;256(21):11224-31
references: 6116713
references: EMBO J. 1999 Oct 1;18(19):5252-63
references: 10508159
references: Biochimie. 1998 Jul;80(7):605-12
references: 9810467
references: J Invest Dermatol. 1999 May;112(5):818-21
references: 10233778
references: Clin Exp Rheumatol. 1986 Jul-Sep;4(3):221-30
references: 3769240
references: J Biol Chem. 2006 Mar 3;281(9):5406-15
references: 16354654
references: Exp Cell Res. 1994 Nov;215(1):154-63
references: 7957663
references: Eur J Cell Biol. 2004 Dec;83(11-12):781-95
references: 15679122
references: Oncogene. 2002 Aug 29;21(38):5951-5
references: 12185597
references: Biochem Mol Biol Int. 1993 Aug;30(5):921-8
references: 8220241
references: J Dermatol Surg Oncol. 1986 Nov;12(11):1156-64
references: 3490500
references: Arthritis Rheum. 1976 Nov-Dec;19(6):1295-307
references: 1036689
references: J Cell Biol. 2005 Jan 31;168(3):489-99
references: 15668295
references: Cancer Res. 1989 Nov 1;49(21):6008-14
references: 2790815
references: J Biol Chem. 1985 Mar 10;260(5):3215-20
references: 3972822
references: Eur J Biochem. 1999 Oct 1;265(1):384-93
references: 10491196
references: Anticancer Res. 2002 Mar-Apr;22(2A):913-9
references: 12014671
references: Curr Pharm Des. 2007;13(3):271-85
references: 17313361
references: Dermatol Clin. 1993 Oct;11(4):647-66
references: 8222349
references: Breast Cancer Res Treat. 1992;22(1):47-57
references: 1421424
references: J Biol Chem. 1994 Feb 4;269(5):3846-51
references: 8106429
references: Br J Dermatol. 2004 Aug;151(2):355-61
references: 15327542
references: Biochem J. 2004 Nov 1;383(Pt. 3):507-15
references: 15255780
references: J Invest Dermatol. 1995 Jun;104(6):982-8
references: 7539470
references: Biochem Soc Trans. 1990 Jun;18(3):367-74
references: 2164980
references: J Pathol. 2003 Jul;200(4):448-64
references: 12845612
references: Lancet. 1989 Nov 11;2(8672):1115-8
references: 2572846
references: Int J Oncol. 2008 Feb;32(2):491-8
references: 18202773
references: Cancer Res. 1989 Jul 15;49(14):3904-9
references: 2736531
references: Cancer Immunol Immunother. 1998 Mar;46(1):48-54
references: 9520292
references: Anticancer Res. 2006 Nov-Dec;26(6B):4163-70
references: 17201128
references: Gynecol Oncol. 1999 Aug;74(2):181-7
references: 10419729
references: Biochem J. 1994 Nov 1;303 ( Pt 3):775-80
references: 7980446
references: Biochemistry. 2006 Dec 26;45(51):15474-82
references: 17176069
references: J Rheumatol. 1976 Dec;3(4):400-8
references: 15110
references: J Biol Chem. 2003 Aug 15;278(33):31401-11
references: 12782632
references: Cancer Gene Ther. 2002 Oct;9(10):854-63
references: 12224027
references: Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6796-800
references: 8393577
references: Eur J Cell Biol. 2007 Jun;86(6):303-13
references: 17532541
references: Biochem J. 1983 Sep 1;213(3):733-40
references: 6225425
references: Crit Rev Oncol Hematol. 2008 Oct;68(1):12-28
references: 18396408
references: Gynecol Oncol. 2004 Jul;94(1):25-32
references: 15262115
references: Annu Rev Biochem. 1986;55:167-93
references: 2943218
references: Eur J Gynaecol Oncol. 2005;26(4):363-71
references: 16122180
references: J Clin Pathol. 1986 Dec;39(12):1323-30
references: 3543065
references: FASEB J. 2000 Mar;14(3):565-71
references: 10698972
references: Comp Biochem Physiol B Biochem Mol Biol. 2002 Sep;133(1):113-8
references: 12223218
references: Anticancer Res. 2004 Sep-Oct;24(5A):2739-43
references: 15517880
references: Mol Endocrinol. 1990 Sep;4(9):1327-35
references: 2172799
references: J Cell Sci. 1995 May;108 ( Pt 5):2001-6
references: 7657720
references: Adv Exp Med Biol. 1995;362:279-83
references: 8540328
references: EMBO J. 1996 Aug 1;15(15):3861-70
references: 8670891
references: Arterioscler Thromb Vasc Biol. 2003 Aug 1;23(8):1430-6
references: 12750117
references: Cancer Lett. 2006 Jun 18;237(2):167-79
references: 16046058
references: Oncogene. 2001 Oct 18;20(47):6920-9
references: 11687971
references: Br J Cancer. 1999 Jan;79(2):300-7
references: 9888472
references: Prostate. 2000 Jun 15;44(1):1-7
references: 10861751
references: Arch Biochem Biophys. 1984 Apr;230(1):375-82
references: 6424571
references: J Cell Sci. 1998 Sep;111 ( Pt 17):2539-49
references: 9701553
references: J Biol Chem. 1980 May 25;255(10):4937-45
references: 6989821
references: Breast Cancer Res Treat. 1999 Oct;57(3):261-9
references: 10617302